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Waste clearance (WC) is an essential process for brain homeostasis, which is required
for the proper and healthy functioning of all cerebrovascular and parenchymal brain
cells. This review features our current understanding of brain WC, both within and
external to the brain parenchyma. We describe the interplay of the blood-brain barrier
(BBB), interstitial fluid (ISF), and perivascular spaces within the brain parenchyma for
brain WC directly into the blood and/or cerebrospinal fluid (CSF). We also discuss the
relevant role of the CSF and its exit routes in mediating WC. Recent discoveries of the
glymphatic system and meningeal lymphatic vessels, and their relevance to brain WC are
highlighted. Controversies related to brain WC research and potential future directions
are presented.
Keywords: cerebrospinal fluid, interstitial fluid, interstitial waste products, arachnoid villi, perineural spaces,
perivascular spaces, glymphatic system, meningeal lymphatics

INTRODUCTION
Homeostasis is critical for the proper functioning of the human body, particularly, homeostasis
of high-energy consuming organs like the brain. The substantial amount of toxic metabolic byproducts/interstitial waste products (such as CO2 , lactate, proteins including amyloid-β (Aβ) and
tau proteins, etc.) released into the brain due to the high metabolic activity of neurons in the brain,
require rapid exit by several WC mechanisms. Otherwise, the accumulation of these metabolic
by-products/interstitial waste products may initiate and or exacerbate several neurological diseases,
including the accumulation of Aβ in Alzheimer’s disease (AD) and tau in traumatic brain injury
(TBI) (Berrouschot et al., 1998; Arbel-Ornath et al., 2013; Hinson et al., 2013; Tsitsopoulos and
Marklund, 2013; Iliff et al., 2014; Kyrtsos and Baras, 2015; Plog et al., 2015; Tarasoff-Conway et al.,
2015; Louveau et al., 2016; Peng et al., 2016; Xia et al., 2017; Da Mesquita et al., 2018b; Goodman
et al., 2018; Reeves et al., 2020), as discussed in detail in ‘‘Waste Clearance Within the Brain
Parenchyma’’ section. Therefore, regulating the entry and exit of various substances in the brain, as
well as recycling of neurotransmitters, are essential for proper neuronal functioning and healthy
aging (Harris et al., 2014; Zhao et al., 2015; Hladky and Barrand, 2016). There are two distinct
systems set in place to help the brain with this type of regulation, the CSF and the vascular systems.
Interestingly, the CSF and BBB are unique to the central nervous system (CNS).
The idea that CSF, which is an ultrafiltrate of the blood secreted at the choroid plexus,
is involved in brain WC via a network of perivascular spaces has existed since at least
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place within and external to the brain parenchyma in the
CNS are connected, and in some instances, affect one
another.

1974 (Cserr and Ostrach, 1974) as indicated in Figure 1A.
But it did not receive much attention until 2012 when
Nedergaard and colleagues expanded our understanding of
the role of CSF in brain WC and proposed the glymphatic
system (Iliff et al., 2012) as indicated in Figure 1Bi. They
and others demonstrated that glymphatic system dysfunction
is associated with a broad range of neurological diseases
including, but not limited to, AD, stroke, TBI, multiple sclerosis,
diabetes, and chronic traumatic encephalopathy, suggesting
its involvement in virtually most neurodegenerative diseases
(Iliff et al., 2012; Arbel-Ornath et al., 2013; Rangroo Thrane
et al., 2013; Jessen et al., 2015; Plog et al., 2015; Louveau
et al., 2016; Jiang et al., 2017; Mestre et al., 2018b, 2020a).
Although dysfunction of the glymphatic system and its impact
on WC from the brain is related to a variety of neurological
diseases, controversial aspects concerning the convective bulk
flow of CSF/ISF within the brain parenchyma and the role of
aquaporin-4 (AQP4) water channels in solute transport in the
glymphatic system still exist (Jin et al., 2016; Smith et al., 2017;
Pizzo et al., 2018; Smith and Verkman, 2018), as discussed
in detail in ‘‘The Glymphatic System’’ section. Augmenting
the importance of the glymphatic system’s role in CNS
homeostasis is the (re)discovery of the previously unappreciated
meningeal lymphatic vessels in the dura (Aspelund et al., 2015;
Louveau et al., 2015), originally proposed at the end of the
18th century (Lukić et al., 2003; Bucchieri et al., 2015; Da
Mesquita et al., 2018a), as indicated in Figure 1Ciii. Two
independent research groups in 2015 confirmed the existence
of the meningeal lymphatic vessels, and furthermore, indicated
that CSF tracers utilize these meningeal lymphatic vessels
for brain WC.
The brain vascular WC involves the BBB as indicated in
Figure 1Bii. The BBB has long been studied, particularly for
its structure and role in pharmaceutical drug entry. However,
its role in brain WC has been understudied. In this review, we
discuss the structure of the BBB and its relationship via various
BBB transfer mechanisms to brain WC. Until recently, the
assumption has been that the BBB lacks directionality. However,
recent studies have challenged this assumption, indicating that
‘‘BBB-impermeable’’ MRI tracers, which were thought not to
cross the BBB from the blood to the brain parenchyma, may be
able to cross the BBB from the brain parenchyma to the blood,
suggesting directionality (Jiang et al., 2018; Hu et al., 2019). In
this review, we further discuss the BBB as it pertains to brain WC.
For this review, we categorized brain WC into two levels:
WC within the brain parenchyma (including the brain stroma
infiltrating the brain parenchyma such as blood vessels and
perivascular spaces) as indicated in Figure 1B, and WC external
to the brain parenchyma as indicated in Figure 1C. The
brain parenchyma consisting primarily of neurons and glial
cells (surrounded by ISF) is the functional tissue for cognitive
and systemic management and is considered responsible for
nutrient uptake, and WC to maintain homeostasis. The
remaining structural tissue in the brain, the stroma, is
comprised primarily of the blood vessels, which provide
the brain with oxygen and nutrients, and connective tissue.
It is important to note that brain WC processes taking
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Fluids in the Brain and Their Functions
CSF Production and Circulation
CSF is produced in the human brain at a rate of about
0.3–0.4 ml/min, mainly by specialized ependymal cells such as
choroid plexus epithelial cells located in each of the ventricles.
The CSF travels from the lateral ventricles to the third ventricle
via the interventricular foramen of Monro and enters the fourth
ventricle via the cerebral aqueduct of Sylvius. CSF then enters
the central canal of the spinal cord via the obex and also reaches
the subarachnoid space via the median aperture of Magendie
and the two lateral apertures of Luschka (Johanson et al., 2008;
Craven, 2010; Brinker et al., 2014; Khasawneh et al., 2018). CSF
is eventually drained via the arachnoid villi, perineural spaces of
spinal and cranial nerves, and meningeal lymphatics, as discussed
in detail in ‘‘Waste Clearance External to the Brain Parenchyma’’
section. However, part of the CSF is also proposed to enter the
brain parenchyma via the periarterial spaces of the penetrating
arteries, mixes with interstitial waste products and ISF, enters the
perivascular spaces (alongside veins by the glymphatic system
or along arteries by IPAD pathway), and finally drains via
the WC pathways, as indicated in Figure 1A, and discussed
in detail in ‘‘Waste Clearance Within the Brain Parenchyma’’
and ‘‘Waste Clearance External to the Brain Parenchyma’’
section.
CSF Functions and Flow Behavior
The CSF has multiple functions in the brain including, providing
buoyancy and buffer against injury, and by serving as the WC
route, it maintains CNS homeostasis. The CSF is also very
important for removing high molecular weight waste products
and other debris during recovery from brain injuries, and it
provides a pathway for nutrients and hormones to promote the
brain’s normal development (Lehtinen et al., 2013; Hladky and
Barrand, 2014).
The flow of CSF in the cerebral aqueduct, in the ventricles,
and the subarachnoid space is pulsatile due to the cardiac flow
(arterial hemodynamics in the choroid plexus) and pulmonary
respiration (Nilsson et al., 1992; Egnor et al., 2002; Johanson
et al., 2008; Brinker et al., 2014; Abbott et al., 2018; Khasawneh
et al., 2018), facilitating rapid influx via the periarterial
spaces into the brain parenchyma. However, within the brain
parenchyma, CSF flow may be either via convective bulk flow
and/or diffusion, as discussed in detail in ‘‘The Glymphatic
System’’ section. A recent article showed that the flow of CSF
in the human brain is also linked with the slow waves of neural
activity and the hemodynamic fluctuations during sleep (Fultz
et al., 2019).
ISF Production and Circulation
ISF is a filtrate of plasma secreted at the BBB of the capillary walls.
ISF surrounds neural cells, makes its way through intercellular
clefts of the neuropil, and is present in the extracellular spaces
of the gray and white matter within the brain parenchyma. It
contains interstitial waste products excreted by the cells due
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FIGURE 1 | Schematic illustration of Waste Clearance (WC) in the brain. (A) Schematic model of cerebrospinal fluid (CSF) flow which is involved in brain WC, both
within (B) and external to the brain parenchyma (C). Dotted arrows show the movement of CSF from the ventricular compartments to the subarachnoid space,
entering the brain parenchyma via periarterial spaces, getting mixed with interstitial waste products as well as interstitial fluid (ISF), entering the perivenous space,
and then draining via perineural spaces and lymphatics. The waste products also reach the vascular compartments directly via the blood-brain barrier (BBB) and
indirectly via CSF exiting through the arachnoid villi/granulations. (Bi) A magnified schematic image of the glymphatic system and intramural periarterial drainage
(IPAD) pathways involved in WC within the brain parenchyma. (Bii) A magnified schematic image of the vascular pathway via the BBB at the capillary level. (C) A
schematic image of the CSF pathways involved in brain WC via the arachnoid villi (Ci), and lymphatic pathways [including the nasal lymphatics (Cii), and the
meningeal lymphatics (Ciii)].
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WASTE CLEARANCE WITHIN THE BRAIN
PARENCHYMA

to cellular metabolism and nutrients from capillaries through
diffusion. ISF acts as an intermediary between blood capillaries
and brain cells for rapid delivery of oxygen and nutrients
(such as glucose, lactate, and amino acids, etc.) for reliable
cellular activity. ISF also acts as a vehicle for rapid removal
of the cellular waste by-products (such as CO2 , lactate, etc.),
and cell-to-cell communication (Abbott, 2004; Howell and
Gottschall, 2012; Hladky and Barrand, 2014; Lei et al., 2017;
Shetty and Zanirati, 2020). The CSF act as a sink for the ISF,
and the CSF-ISF exchange helps in the removal of interstitial
waste products from the brain parenchyma, as discussed in
detail in ‘‘Waste Clearance Within the Brain Parenchyma’’
section.

Most neurodegenerative diseases are related to the improper
accumulation of cellular waste by-products. Among them,
misfolded proteins are the most difficult to clear from the
brain, and their build-up leads to diseases such as AD
(Nedergaard, 2013). Although chaperone proteins in brain cells
help proteins fold correctly and limit their aggregation, folding
and aggregation errors do occur, and some proteins are more
vulnerable than others. If misfolded proteins are not identified
and removed from the brain parenchyma, then these interstitial
waste products can cause or exacerbate neurological diseases
(Powers et al., 2009; Hartl et al., 2011; Wolfe, 2012). Aβ and
tau proteins are the two most concerning neurotoxic waste
proteins due to their accumulation in the brain and association
with neurological diseases such as AD and TBI (Berrouschot
et al., 1998; Arbel-Ornath et al., 2013; Hinson et al., 2013;
Tsitsopoulos and Marklund, 2013; Iliff et al., 2014; Kyrtsos and
Baras, 2015; Plog et al., 2015; Tarasoff-Conway et al., 2015;
Louveau et al., 2016; Peng et al., 2016; Xia et al., 2017; Da
Mesquita et al., 2018b; Goodman et al., 2018; Reeves et al., 2020).
Aβ is a small protein fragment that is cleaved from a larger
amyloid precursor protein, which extends from the inside to
the outside of brain cells. Aβ eventually forms amyloid-plaques
in the extracellular spaces of the brain parenchyma, found in
AD patients (Murphy and LeVine, 2010; Haass et al., 2012).
These Aβ aggregates impair communication between neuronal
cells, cause nerve inflammation, and are a common cause of
dementia in the elderly. In transgenic mouse models of AD,
intracellular Aβ has been associated with cognitive deficits,
tau-phosphorylation, synaptic dysfunction, and neuronal death
(LaFerla et al., 2007).
Tau protein is an intracellular protein that mainly exists
in neurons and helps stabilize microtubules. They are
released to the extracellular space after a rapid increase in
neuronal activity (Yamada et al., 2014). When misfolded
and hyperphosphorylated, tau proteins create neurofibrillary
tangles which disrupt neuronal signal transmission, cause
microtubules to disassemble, and promote mitochondrial
dysfunction. In addition to Aβ protein, tau protein is also
one of the main features of AD (Gong and Iqbal, 2008;
Mandelkow and Mandelkow, 2012). In a recent study, it
has been suggested that both extracellular Aβ plaques and
intracellular tau neurofibrillary tangles work together in
synergy in generating AD (Busche and Hyman, 2020). The
accumulation and movement of tau protein in the extracellular
space have been related to many neurodegenerative diseases,
such as chronic traumatic encephalopathy, Parkinson’’s disease,
prion disease, etc. (Frost and Diamond, 2010; Jucker and
Walker, 2011; Iliff et al., 2014; Pirscoveanu et al., 2017;
Edwards et al., 2020). Since the Aβ and tau accumulation
impairs neurons, they need constant maintenance and repair,
which are essential for learning, memory, and neurological
function.
In some instances, the waste products of certain cells can be
the fuel for other types of cells. For a long time, the metabolic

Barriers (BBB and Blood-CSF Barrier) and Their
Functions
CSF and ISF are similar in composition, however, the CSF is
mainly present in the cerebral ventricles and subarachnoid space
covering the entire brain, whereas the ISF is extracellular fluid
and surrounds the cells in the brain parenchyma. Regulation
of ionic composition (such as Na+ , Cl− , K+ , Ca2+ , Mg2+ , etc.)
and volumes of these fluids is essential for the brain cells to
function effectively and is supported by barriers such as the
BBB and blood-CSF barrier (Hladky and Barrand, 2014). The
BBB separates blood in the vasculature from ISF and cells
within the brain parenchyma and helps in maintaining the
ionic composition of ISF. The BBB restricts the movement of
many substances from the brain parenchyma while delivering
substrates (glucose, amino acids, O2 , etc.) for brain cell
metabolism and helps in WC, as discussed in detail in ‘‘Vascular
Pathway via the BBB’’ section (Hladky and Barrand, 2014, 2016).
Unlike the capillaries that form the BBB, the capillaries
that supply the choroid plexuses and the circumventricular
organs are fenestrated/leaky and have no tight junctions that
is an essential property of the BBB (Laterra et al., 1999).
However, the ependymal cells of the choroid plexuses, facing
the ventricular CSF possess many microvilli consisting of a
layer of cuboidal epithelial cells (having apical brush borders)
overlying capillaries of the fenestrated type. The choroidal
epithelial cells are connected by tight junctions and constitute
the blood–CSF barrier (Cipolla, 2009; Hladky and Barrand,
2014, 2016). The blood–CSF barrier separates blood in the
capillaries from the CSF, and CSF from the brain tissue
and ISF, regulating the passage of molecules between them.
Another type of specialized ependymal cells called tanycytes,
present along the ventricular boundaries of the circumventricular
organs and located around the third and fourth ventricles,
also form a blood-CSF barrier (Nakada and Kwee, 2019).
These specialized cells are different from other ependymal cells
because they possess long processes as well as large end-feet.
They connect to the fenestrated capillaries and neurons in
the hypothalamic parenchyma utilizing their long processes,
prevent the diffusion of molecules from the blood into the
CSF utilizing their tight junctions, and maintain the brain
homeostasis (Weindl and Joynt, 1972; Mullier et al., 2010;
Langlet et al., 2013; Hladky and Barrand, 2014; Abbott et al.,
2018).
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Aβ (Shibata et al., 2000; Bell et al., 2007; Qosa et al.,
2014), insulin (Duffy and Pardridge, 1987), and transferrin
(Banks et al., 1988), also exit via the BBB with the help of
transcytosis. Yet other substances are first metabolized to other
products (such as glucose metabolizing to CO2 and water)
before exiting. However, Na+ , Cl− , and water are transported
by both vascular and CSF pathways (Hladky and Barrand,
2018).

waste product ‘‘lactic acid’’ released by astrocytes in the brain
was regarded as a waste product, however, it has been shown
to be an important fuel for many cells (including neurons; Proia
et al., 2016). In the brain, lactic acid is absorbed by neurons as
fuel and used to synthesize acetyl-CoA for the tricarboxylic acid
cycle. It also acts as a signal molecule in the brain, participates
in memory formation, and provides neuroprotection (Gladden,
2004; Berthet et al., 2012; Proia et al., 2016).
Also, in the CNS, neurotransmitters (such as acetylcholine,
dopamine, glutamate, serotonin, norepinephrine, etc.) play
a key role in the transmission of information in chemical
synapses, and even small changes in their concentrations may
lead to neurodegenerative diseases (Harris et al., 2014). So,
the release and recycling of neurotransmitters in the brain
parenchyma are very important for the normal function of
neurons. As an action potential propagates to the terminal of
a presynaptic neuron, vesicles storing the neurotransmitter
fuse with the cell membrane and release the neurotransmitter
into the synapse. Once the neurotransmitter is secreted
into the synaptic cleft, it binds to specific receptors on the
postsynaptic cell, thereby generating a postsynaptic electrical
signal, initiating rapid communication between neurons.
Then the transmitter must be cleared quickly or chemically
inactivated so that the postsynaptic cell can participate
in another cycle of neurotransmitter release, binding, and
signaling.
Neurotransmitter clearance mechanisms include diffusion,
enzymatic degradation, reuptake by presynaptic nerve terminals,
uptake by glial cells through transporters located primarily
on the surface of glial cells (Rothstein et al., 1996; Purves
et al., 2001; Chaturvedi et al., 2014; Harris et al., 2014;
Gross and von Gersdorff, 2016). If these mechanisms are
deregulated, the dysfunctional neurotransmitter signaling can
negatively alter brain function such as the increased release of
presynaptic neurotransmitter, direct release of neurotransmitter
from glial cells, impaired ability to clear neurotransmitter from
the extracellular space which may lead to excessive stimulation
of neurotransmitter receptors, resulting in neurotoxicity, and
dysfunctional neurotransmitter signaling is implicated in various
diseases (Caudle et al., 2007; Bisaglia et al., 2013; Paula-Lima
et al., 2013; Harris et al., 2014).
The brain parenchyma (which consists of the neurons and
glial cells) is infiltrated by the brain stroma (which contains
the blood vessels and perivascular spaces) and lacks lymphatic
vessels. WC at this level consists of the interaction of the brain
parenchyma with the blood vessels and perivascular spaces,
which eventually help transport the waste products outside the
cranium. Therefore, waste products can only be removed from
the brain parenchyma by: (a) CSF pathways via the perivascular
(as indicated in Figure 1Bi) and periaxonal/perineural routes;
(b) the vascular pathway via the BBB as indicated in Figure 1Bii.
Waste products which are small in size (such as CO2 , K+ ,
lactate, etc.) exit via the BBB. Whereas, waste products which
are larger in size, polar in nature (such as sucrose, inulin,
albumin, dextran, etc.), and lack specific transporters to cross
the BBB, exit via perivascular or periaxonal/perineural routes.
However, special solutes which are larger in size, such as
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CSF Pathways via the Perivascular and
Periaxonal/Perineural Spaces
The idea that CSF infiltrates the brain parenchyma and is
involved in WC has been around for a long time. There
is an agreement in the field regarding the utility of the
perivascular spaces in CSF-related WC. However, the exact
pathway undertaken by CSF-related WC inside the brain
parenchyma, as pertaining to the perivascular spaces, is very
much under debate. Thus far, two pathways have been strongly
put forward: the intramural periarterial drainage (IPAD) and the
glymphatic system. These pathways are discussed at length in
this section. There appears to be consensus in the field regarding
the utility of the periaxonal/perineural spaces in CSF-related
WC (which span brain WC within and external to the brain
parenchyma).

Perivascular Spaces
By looking at the distribution of dye ‘‘blue dextran 2000KDa’’
(Cserr and Ostrach, 1974) and ‘‘horseradish peroxidase’’ injected
into the caudate nucleus of rats, Cserr et al. (1977) demonstrated
that the interstitial fluid (ISF) interacts with and drains into
the CSF via bulk flow along the cerebral blood vessels (i.e., the
perivascular spaces). The convective bulk flow transport of
tracers was also observed in the periventricular regions and
between the fiber tracts in the white matter (Cserr et al., 1977).
Subsequent experiments demonstrated similar efflux rates of
various radiolabeled tracers from the brain ISF, despite big
differences in their molecular size and diffusion coefficients,
implying the convective bulk flow nature of clearance from
the brain parenchyma (Cserr et al., 1977, 1981). Moreover,
microinjection of radio-iodinated albumin into the caudate
nucleus, internal capsule, or midbrain suggests ISF drainage out
of the brain parenchyma along blood vasculature (Szentistvanyi
et al., 1984).
Further insights by Rennels et al. (1985, 1990) suggest that
CSF may enter into the brain parenchyma via perivascular
spaces, and they demonstrated a perivascular distribution
of horseradish peroxidase (HRP) when injected into the
subarachnoid space of cats and dogs. HRP tracer was present
in the perivascular spaces along large penetrating arteries,
into the basal lamina of capillaries, venules, and perivascular
spaces of veins. The HRP reached extracellular spaces (ECS)
throughout the CNS via paravascular pathways (i.e., CSF
fluid pathways) present along intraparenchymal vasculature in
∼10 min; suggesting the exchange of solutes in CSF with the
ECS by a convective bulk flow supported by cerebral arterial
pulsations rather than by diffusion alone (Rennels et al., 1985,
1990).

5

July 2021 | Volume 15 | Article 665803

Kaur et al.

Waste Clearance in the Brain

unrestricted movement of small molecular weight tracers into the
interstitium. However, large molecular weight CSF fluorescent
tracer [fluorescein isothiocyanate-dextran-2000 (FITC-d2000):
molecular size, 2,000 kD] predominantly remained confined in
the periarterial spaces; highlighting the role of the 20 nm-wide
astrocytic end-feet gap junctions (Iliff et al., 2012). The
observation that both small and large molecular weight tracers
entered perivascular spaces alongside arteries indicates that
the transport is facilitated by CSF convective bulk flow via
perivascular spaces.
Transport by AQP4 water channels is thought to play a
dominant role in mediating brain parenchymal entry of CSF
tracer from the periarterial spaces (Iliff et al., 2012; Mestre et al.,
2018a), which is driven by the hydrostatic pressure generated by
arterial pulsations as proposed in the glymphatic system (Iliff
et al., 2013b). Cerebral arterial pulsations are said to drive the
CSF convective bulk flow in the perivascular spaces and are
the key contributors of CSF entry into the brain parenchyma
allowing CSF-ISF fluid exchange in the glymphatic system (Iliff
et al., 2013b; Mestre et al., 2018b). Additionally, astroglial
AQP4 support the convective bulk flow of ISF through the
brain parenchyma to drive the interstitial waste products (Aβ) to
the perivenous spaces; in AQP4-null mice, the interstitial waste
products clearance is reduced by nearly 70% (demonstrated using
intraparenchymal injections in mice; Iliff et al., 2012).
The CSF mixed with ISF and interstitial waste products such
as Aβ is drained primarily through the perivenous spaces, which
may then reenter associated CSF compartments, either within the
ventricles (for internal cerebral veins), or in the subarachnoid
space (for caudal rhinal veins) (Iliff et al., 2012), or may
drain to the blood across the vasculature via specific transport
mechanisms at the BBB (Iliff et al., 2012; Ueno et al., 2016; Hladky
and Barrand, 2018; Jiang et al., 2018; Hu et al., 2019). The waste
products, which reach the CSF in subarachnoid space may then
exit the cranium either via arachnoid granulations or meningeal
lymphatic vessels or along cranial and spinal nerves (Ueno
et al., 2016; Louveau et al., 2017; Hladky and Barrand, 2018)
as indicated in Figure 1A, and discussed in ‘‘Waste Clearance
External to the Brain Parenchyma’’. However, and as an attempt
to reconcile the IPAD and the glymphatic system pathways,
some speculate that the CSF-ISF mixture may recirculate in the
brain parenchyma via periarterial spaces and accumulate within
the basement membranes of smooth muscle cells, triggering
neurological conditions (Iliff et al., 2012).
The glymphatic system impacts the physiology of the body,
such as sleep (Nedergaard and Goldman, 2016), body posture
(Lee et al., 2015), blood pressure (Kyrtsos and Baras, 2015),
aging (Zieman et al., 2005; Chen et al., 2009; Fleischman et al.,
2012; Iliff et al., 2013b; Kress et al., 2014; Jessen et al., 2015;
Kyrtsos and Baras, 2015; Da Mesquita et al., 2018b; Zhou
et al., 2020), anesthesia (Benveniste et al., 2017a), etc. Slight
changes in normal physiology can affect the clearance rate of
interstitial waste products from the brain. The glymphatic system
helps in the removal of Aβ, a protein which is a trademark of
AD, from the brain (Iliff et al., 2012; Tarasoff-Conway et al.,
2015; Simon and Iliff, 2016). Decreased glymphatic clearance
and increased Aβ accumulation have been seen in the aged

Intramural Periarterial Drainage (IPAD)
A study in 2008, in which various soluble tracers were injected
into the corpus striatum of mice, demonstrated diffusion of
tracers through the extracellular spaces of the brain parenchyma
and then convective bulk flow drainage along the basement
membrane of capillaries and arterial walls. This indicated that
ISF and waste products drain via the same pathway, termed
IPAD (Carare et al., 2008); joining the CSF in the subarachnoid
space or dissipation at the base of the skull for further
drainage into the cervical lymph nodes (CLNs) and/or blood. A
recent study in mice demonstrated that following injection of
fluorescent Aβ into the cisterna magna, the CSF tracer enters
the brain parenchyma along pial-glial basement membranes.
It then mixes with ISF and interstitial waste products and
exits along the basement membranes in the walls of capillaries
and the basement membranes between smooth muscle cells in
the walls of the cortical arteries (IPAD pathway; Albargothy
et al., 2018) as indicated in Figure 1Bi. Other studies using
mathematical and computational models suggest that arterial
pulsations, which were initially considered as a motive force
for IPAD, cannot be the only driving force for the IPAD
pathway to efficiently account for the experimental observations
(Diem et al., 2017); however, vasomotion induced by contraction
and relaxation of cerebrovascular smooth muscle cells are
suggested to be a more plausible driver for IPAD (Aldea et al.,
2019).
The Glymphatic System
In 2012, Nedergaard and colleagues performed a series of
fluorescence microscopy experiments that demonstrated the
path of CSF circulation within the brain parenchyma via a
network of perivascular spaces, termed the glymphatic system.
The glymphatic system hypothesis describes subarachnoid CSF
entry into the brain parenchyma through the periarterial
spaces, mixing with parenchymal ISF and interstitial waste
products facilitated by AQP4 water channels embedded in
astrocytic end-feet, and drainage through perivenous spaces
surrounding the veins (Iliff et al., 2012, 2013a; Nedergaard,
2013; Rangroo Thrane et al., 2013; Xie et al., 2013; Plog et al.,
2015; Nedergaard and Goldman, 2016; Benveniste et al., 2017b)
as indicated in Figure 1Bi. So whereas the IPAD pathway
demonstrated CSF brain parenchymal circulation through the
separate periarterial basement membranes (convective influx
along pial-glial basement membranes as suggested in the
glymphatic pathway and the efflux along basement membranes
between smooth muscle cells in the walls of arteries (Albargothy
et al., 2018), the glymphatic system pathway demonstrated CSF
circulation via the perivascular spaces surrounding the arteries
and veins.
Specifically, Nedergaard and colleagues injected tracers
into the cisterna magna of mice and two-photon imaging
studies of these mice indicated that the tracer size matters
when determining brain parenchymal tracer distribution (Iliff
et al., 2012). Small molecular weight CSF fluorescent tracer
[Texas Red–dextran-3 (TR-d3): molecular size, 3 kD] injected
into mouse cisterna magna was observed within periarterial
spaces and within brain parenchyma within 30 min; indicating
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differ in describing the fluid motion and its associated properties.
The Eulerian approach identifies the fixed location in a flow field
and tracks the properties (such as temperature, concentration,
etc.) at the same location as the fluid passes with time. However,
the Lagrangian approach identifies the particles in the fluid and
tracks them as they move with time along with their properties
(such as velocity, temperature, density, mass, concentration,
etc.). The Lagrangian approach is advantageous over the Eulerian
approach to envision the time-varying trajectories of particles in
a single visualization (Elkin et al., 2020).
Various studies suggested the presence of the glymphatic
system in the human brain consistent with the animal studies
(Eidsvaag et al., 2017; Ringstad et al., 2017; Eide et al., 2018;
Ringstad et al., 2018; Eide and Ringstad, 2019a,b; Watts et al.,
2019). Ringstad et al. (2017) pioneered the use of MRI to
study the glymphatic system in patients with idiopathic normal
pressure hydrocephalus (iNPH) and found a delay in the
clearance of CSF tracer (gadobutrol) from the subarachnoid
space and brain parenchyma compared to the healthy reference
group. They also suggested the increase in glymphatic system
clearance during sleep. Eide et al. (2018) demonstrated in vivo
CSF tracer drainage to the cervical lymph nodes in humans at
the same time corresponding to the peak CSF tracer uptake
by the glymphatic system. Ringstad et al. (2018) examined the
brain-wide glymphatic enhancement of CSF tracer (gadobutrol)
using MRI for time points up to 4 weeks and showed delayed
clearance in iNPH patients compared to healthy individuals.
CSF tracer uptake in the human brain was slower compared to
the rodent brain which may be due to physiological differences
between human and rodent brain such as difference in vascular
pulsatility, metabolic rate, brain mass, AQP4 density, et cetera
(Benveniste et al., 2019). Watts et al. (2019) demonstrated a
quantitative glymphatic flow in a man utilizing MRI imaging
before and after intrathecal injection of CSF tracer (gadobutrol).
Also, based on MRI data in iNPH patients, it has been
proposed that reduced CSF clearance in the entorhinal cortex
and white matter is associated with the impairment of the
glymphatic system, which might be the cause of dementia in
iNPH (Eide and Ringstad, 2019a,b). A recent human study
utilized MRI to identify the clearance of MRI contrast agent
(gadodiamide) in the glymphatic system and the existence
of putative meningeal lymphatic vessels and suggested the
impairment of both pathways with aging (Zhou et al., 2020),
consistent with the animal studies.
There are some controversial aspects related to the glymphatic
system hypothesis primarily based on: (a) convective bulk flow
within the brain parenchyma; and (b) AQP4 dependent solute
transport within the brain parenchyma. (a) The glymphatic
system proposed the size-independent convective bulk flow of
solutes within the brain parenchyma. Some experiments in the
past also demonstrated the similar convective bulk flow nature
of solute clearance from the brain parenchyma independent of
their molecular size (Cserr et al., 1977, 1981; Rennels et al., 1985,
1990). However, Smith et al. (2017) recently demonstrated a
diffusive transport in the brain parenchyma dependent on the
solute size, consistent with their diffusion coefficients. Moreover,
some modeling studies showed the movement of tracer through

brain (Kress et al., 2014), sleep deprivation (Xie et al., 2013),
depression (Xia et al., 2017), and obstructive sleep apnea (Ju
et al., 2016). Whereas, voluntary exercise (He et al., 2017) and
Omega-3 polyunsaturated fatty acids (Ren et al., 2017) promote
the glymphatic clearance of Aβ. Dysfunction/impairment of the
glymphatic system has been associated with several neurological
diseases including AD (Zarow et al., 2003; Peng et al., 2016;
Reeves et al., 2020), TBI (Mondello et al., 2011; Morris et al.,
2011; Magnoni et al., 2012; Tsitsopoulos and Marklund, 2013;
Iliff et al., 2014; Jessen et al., 2015; Plog et al., 2015), small
vessel disease (SVD) (Charidimou et al., 2016; Mestre et al.,
2017), stroke (Gaberel et al., 2014; Goulay et al., 2017; Mestre
et al., 2020a), diabetes (Jiang et al., 2017), microinfarcts (Venkat
et al., 2017; Wang et al., 2017), migraines (Schain et al., 2017),
glaucoma (Wostyn et al., 2017), etc. In most of the studies
relating glymphatic system impairments to neurological diseases,
it is not clear if the impairments are the cause or the result
of these diseases, and therefore the coupling of glymphatic
system impairment and neurological diseases requires further
investigation (Mestre et al., 2017).
Various modeling techniques such as multi-compartment
kinetic models (Lee et al., 2015; Davoodi-Bojd et al., 2019),
optimal mass transport models using Eulerian (Ratner et al.,
2015, 2017), and Lagrangian (Elkin et al., 2018, 2020) approaches
have been implemented using data from MRI to visualize the
dynamics of the glymphatic system. Lee et al. (2015) utilized a
two-compartment model based on contrast-enhanced MRI data
of CSF (Gd-DTPA) tracer and suggested that glymphatic system
transport is most efficient in rats sleeping in the lateral position
as compared to prone and supine positions. The limitation of this
model includes the use of a global input function that cannot
provide accurate measurements for local regions, respectively
(Davoodi-Bojd et al., 2019). Davoodi-Bojd et al. (2019) by
utilizing the local input function for each region, employed the
multi-compartment model to quantitatively map the glymphatic
system pathway and derived associated parameters. This model
also suggested the reduced clearance in the diabetes mellitus rats,
in agreement with the previous findings (Jiang et al., 2017). The
limitation of this model lies in the absence of a diffusion term,
which may cause errors in WC within the brain parenchyma.
Ratner et al. (2015, 2017) used the optimal mass transport
algorithm with the Eulerian approach to identify the fluid
flow patterns in the glymphatic transport and to ascertain its
function in normal and therapeutic conditions. The optimal mass
transport technique provided a good estimate of the glymphatic
flow directionality; however, it did not provide a quantitative
evaluation of glymphatic transport as well as efflux pathways
out of the brain. Later, Elkin et al. (2018, 2020) measured the
glymphatic transport using the optimal mass transport algorithm
with the Lagrangian approach instead of the Eulerian approach.
Their model based on an adjusted continuity equation was able
to distinguish the glymphatic flow patterns in rats under two
different anesthetics. The main advantage of this model is that
compared with the traditional optimal mass transport model,
it not only reduced the error by five times, but at the same
time, it provides qualitative information about fluid flow, rather
than quantitative information. Eulerian and Lagrangian methods
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The inconsistencies in the results of the glymphatic system
between two research groups Smith et al. (2017) and Iliff et al.
(2012) are suggested to be due to some technical differences in
their experimental procedures including, the intraparenchymal
injections, choice of anesthesia, and mice of different ages.
Smith et al., 2017 inserted a beveled glass micropipette
∼20 mm in diameter into the cisterna magna as well as striatum
for pulsed pressure injections, whereas (Iliff et al., 2012) used
a 30–33 gauge metal syringe for constant flow rate injections
into the cisterna magna and brain parenchyma. A recent study
demonstrated that the surgical procedure associated with the
glass micropipette for injection into the striatum or cortex as used
by Smith et al. (2017) acutely suppressed CSF tracer influx into
the brain parenchyma, suggesting that this type of procedure is
traumatic and should be avoided for glymphatic studies (Mestre
et al., 2018a). Concerning this, another study in the past showed
that the cannula insertion into the striatum of the rats and
the rate of drug infusion significantly affect the convective
distribution of molecules in the process of convection-enhanced
delivery (CED) of therapeutic drugs; also suggesting a tissue
distortion caused by cannula (Chen et al., 1999). Another
CED study showed that due to a slight difference (∼1 mm)
between the cannula placement in the two sites of the rat’s
ventral hippocampus, the distribution pattern of the tracer was
different. When the cannula was inserted into the hippocampus
CA1 subfield, the infusate occupied the hippocampus, dentate
gyrus, and CSF regions (ventricles, velum interpositum, and
midbrain cisterns). However, when the cannula was inserted
between the alveus and the corpus callosum, the preferred
distribution along the direction of axonal fiber tracts of the
white matter was determined. The tracer occupied the alveus
and fimbria of the hippocampus, corpus callosum, and minute
amounts reached into the CSF space (Kim et al., 2012).
Also, Smith et al., 2017 used avertin as an anesthetic agent
compared to ketamine/xylazine used by Iliff et al. (2012). A
recent article by Hablitz et al. showed that anesthetic choice
by Smith et al. (2017) may have caused the discrepancy in
results. They tested glymphatic CSF tracer influx in mice using
six different anesthetic agents and found that glymphatic influx
was highest under ketamine/xylazine anesthesia, followed by
isoflurane along with dexmedetomidine and then pentobarbital.
Anesthetic agents α-chloralose, avertin and, isoflurane exhibited
low glymphatic tracer influx (Hablitz et al., 2019).
Another difference is that used mice of either sex and
3–6 months of age whereas Iliff et al. used male mice 8–12 weeks
of age. Since the CSF-ISF exchange dramatically decreases with
age (Kress et al., 2014), it has been suggested by Mestre et al.
(2020b) that it is crucial to compare the mice within the narrow
age range as done by Iliff et al. (2012).
Besides that, recent studies using in vivo observation of
periarterial space geometry demonstrated that the periarterial
spaces are not actually in the shape of circular annula as
represented in most of the mathematical models; instead, the
outer boundaries of periarterial spaces are oblate and should
best be represented as circles surrounded by ellipses, which
have much less hydraulic resistance by several folds (Tithof
et al., 2019). Our previous review article provides information on

extracellular spaces in the brain parenchyma primarily by
diffusion rather than a convective bulk flow, inconsistent with
the glymphatic hypothesis (Jin et al., 2016; Holter et al., 2017).
Similarly, numerous studies in the past utilizing a variety of
tracers have also concluded the diffusion-based solute movement
within the brain parenchyma (Rall et al., 1962; Brightman and
Reese, 1969; Levin et al., 1970; Patlak and Fenstermacher, 1975;
Tao and Nicholson, 1996; Brightman, 2002). In addition, early
and more recent studies indicate that high hydraulic resistance
from tight (38–64 nm) and tortuous extracellular spaces cannot
allow bulk flow even if there is a substantial pressure difference
between the periarterial and perivenous spaces to drive the
convective bulk flow (Fenstermacher and Patlak, 1976; Thorne
and Nicholson, 2006; Sykova and Nicholson, 2008; Verkman,
2013; Wolak and Thorne, 2013; Holter et al., 2017; Pizzo and
Thorne, 2017; Pizzo et al., 2018).
However, more recent articles (Ray et al., 2019; Thomas,
2019; Mestre et al., 2020b) and a new model utilizing the
Lagrangian approach for optimal mass transport reveals that
convective bulk flow is the dominant transport mechanism in
the perivascular spaces; while both, convective bulk flow and
diffusion, are important mechanisms for transport within the
brain parenchyma (Koundal et al., 2020). Based on the available
evidence, it is also likely that CSF enters into the periarterial
spaces of large vessels via convective bulk flow, enters the
brain parenchyma, and mixes with ISF and waste products via
diffusion at the level of capillary/microvessels as suggested by
several groups (Smith et al., 2015; Asgari et al., 2016; Jin et al.,
2016; Holter et al., 2017; Smith et al., 2017; Hannocks et al., 2018;
Pizzo et al., 2018), with a possibility of pericapillary convective
bulk flow along with diffusion in the basal lamina to connect to
the perivascular spaces of arterioles and venules and finally drains
via perivenous spaces (Abbott et al., 2018). However, the debate
remains whether the convective bulk flow is restricted only to the
perivascular spaces or occurs within the brain parenchyma along
with the diffusion.
(b) The role of AQP4 water channels in convective glymphatic
transport has been questioned. Smith et al. (2017) demonstrated
that in AQP4 null mice, the transfer of fluorescent solutes from
CSF into the brain parenchyma was not impaired compared
to wild-type mice; inconsistent with glymphatic studies. Later,
these results were investigated by five different lab groups in
AQP4 knockout mice and it was demonstrated that influx of
CSF tracer into the brain parenchyma was significantly impaired
compared to wild-type controls; suggesting CSF influx and ISF
efflux are highly dependent on AQP4 water channels (Mestre
et al., 2018a).
The constant flow injection technique used by Iliff et al.
(2012) in glymphatic studies has also been questioned because
of its possibility to cause an increase in the intracranial pressure
and contribution to parenchymal tracer distribution (Smith
and Verkman, 2018). However, Mestre et al. (2020b) suggested
that by the time CSF tracer enters into the brain parenchyma,
intracranial pressure already returns to baseline. Also, it has been
shown that even a six-fold difference in CSF tracer infusion speed
does not influence the mean CSF speed in the perivascular spaces
(Bedussi et al., 2018; Mestre et al., 2018b, 2020b).
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products such as water, ethanol, methanol, glycerol, urea,
isopropanol, ethylene glycol, etc. must pass/diffuse through
the endothelial cell, crossing both the luminal and abluminal
membranes (Hladky and Barrand, 2018). Yet other non-specific
substances such as ‘‘BBB-impermeable’’ MRI tracers which
classically cannot cross the BBB from the blood to the brain
parenchyma, may be able to cross the BBB from the brain
parenchyma to the blood; suggesting BBB directionality to
non-specific substances, an important area of research requiring
further investigation (Jiang et al., 2018; Hu et al., 2019).

various MRI studies related to the glymphatic system, modeling
techniques used to evaluate the glymphatic flow pathways,
the association of normal physiology and neurological diseases
with the glymphatic system, and deficiencies in the current
understanding of the glymphatic system (Kaur et al., 2020).

Periaxonal/Perineural Spaces
Various studies have indicated that there is a fast efflux of ISF and
waste products along white matter/axon tracts, in addition to the
perivascular spaces discussed above (Cserr et al., 1977; Rosenberg
et al., 1980; Abbott, 2004; Sykova and Nicholson, 2008; Brinker
et al., 2014). As a gross extension of this, perineural spaces along
all twelve pairs of cranial nerves are also involved in CSF-related
WC; particularly the olfactory (CNI) and optic (CNII) cranial
nerves, as they are anatomically and histologically considered as
white matter tract extensions (Mabray et al., 2015). All the cranial
nerves’ nuclei/cell bodies lie within the brain parenchyma. CNI
and CNII emerge/originate from the cerebrum (CNI from the
olfactory bulb and CNII from the lateral geniculate nuclei), and
the rest of the cranial nerves (III-XII) have their cell bodies in
the brainstem. After emerging, cranial nerves travel within the
skull and then exit via foramina in the skull to reach their final
destinations (Mabray et al., 2015; Krainik and Casselman, 2020).
Therefore, perineural spaces accompanying the cranial nerves
start within the brain parenchyma and make their way outside
the brain parenchyma, along the cranial nerves as indicated in
Figure 1A. The role of the perineural spaces in CSF-related WC
is further discussed in the next section (WC external to the brain
parenchyma).

Efflux Transporters
Various efflux transporters are present at the BBB such as
monocarboxylate transporter 1 (MCT1) for the efflux of lactic
acid and small monocarboxylic acids, glucose transporter 1
(GLUT1) for the transport of glucose, etc. (Hladky and Barrand,
2018). Various ATP-Binding Cassette (ABC) transporters (such
as P-glycoprotein, MRP2, and BCRP) (Cordon-Cardo et al.,
1989; Sugawara et al., 1990; Hartz and Bauer, 2011) and
solute carrier (SLC) transporters are also present at the
BBB. The influx of chemotherapeutic neurotoxic agents (such
as vincristine and doxorubicin) from blood to the brain
parenchyma are prevented by the presence of P-glycoprotein
(ABC transporter) at the luminal membrane of the BBB (Tatsuta
et al., 1992; Virgintino et al., 2002; Chaves et al., 2014; Qosa
et al., 2015; Hladky and Barrand, 2018). The absence of
P-glycoprotein showed elevated drug levels (such as neurotoxic
pesticide ivermectin, and carcinostatic drug vinblastine) in
knockout mice brain (Schinkel et al., 1994; Geyer et al.,
2009). SLC transporters move the waste products from the
brain parenchyma to the endothelial cells, and then, either
ABC or SLC transporters may drain these products further
from the endothelial cells to the blood (Hladky and Barrand,
2018).

Vascular Pathway via the BBB
The BBB consists of continuous endothelial cells joined together
with tight junctions which are further supported by pericytes,
the basement membrane, and the astrocytic endfeet. The
microvascular network in the brain is composed of arterioles,
venules, and capillaries. They all display the BBB properties,
however, capillaries represent the largest microvasculature with
the tightest junctions at BBB as compared to arterioles and
venules (Wilhelm et al., 2016; Sweeney et al., 2019). The BBB
makes the vascular pathway highly selective, as compared to
the CSF pathways, due to the presence of tight junctions in the
gaps between endothelial cells as indicated in Figure 1Bii. The
effective exchange of products between the brain parenchyma
and blood is very important for the influx of various nutrients
and the efflux of metabolic waste products-critical for proper
neuronal functioning. Glucose, CO2 , O2 , water, and amino
acids are some of the major substances that must be rapidly
transported in and out of the brain parenchyma in large
quantities to maintain brain homeostasis. Mechanisms of BBB
transfer (Hladky and Barrand, 2016, 2018) include:

Transcytosis
Efflux by transcytosis includes adsorptive-mediated transcytosis
(AMT) and receptor-mediated transcytosis (RMT) for the
transport of large substrates across the BBB. However, there
is little evidence for transcytosis in the direction of the brain
parenchyma to the blood, although this parenchymal-blood
transcytosis has been reported in studies involving the transport
of Aβ peptides (Shibata et al., 2000; Bell et al., 2007; Qosa
et al., 2014), IgG molecules (Zhang and Pardridge, 2001; Deane
et al., 2005), insulin (Duffy and Pardridge, 1987), and transferrin
(Banks et al., 1988) via the interaction with various receptor
proteins.
Other non-specific substances such as albumin, inulin,
sucrose, and dextran mainly exit the brain parenchyma via
convective bulk flow through the perivascular spaces. For more
details, refer to the thorough review article by Hladky and
Barrand (2018).

Passive, Non-specific Transport
A passive, non-specific transfer can occur via a paracellular or
transcellular pathway. Due to the presence of tight junctions at
the BBB, the paracellular pathway is highly restricted compared
to the transcellular pathway; however, this pathway is still
permeable to small solutes. Most of the passive, non-specific
transfer occurs via a transcellular pathway in which waste
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blood, then they straightforwardly enter the highly specialized
regional parenchymal venous circulation, which eventually
drains into the dural venous sinuses, rejoining the internal
jugular vein through the sigmoid sinus (Singh, 2009). However,
if waste products enter the CSF compartments, several efflux
routes participate in WC. Waste products that reach CSF
from the brain parenchyma can be further taken out of
the cranium via the proposed CSF outflow pathways: the
arachnoid villi/granulations pathway and lymphatic pathways
[which include peripheral lymphatic pathways via perineural
spaces and meningeal lymphatic pathways] as indicated in
Figure 1C.

Clark, 1920). However, they start to degenerate and lose their
efficiency with old age, which may result in the stagnation of CSF
and impaired clearance of toxic waste products from the brain
(Rubenstein, 1998). Perfusion studies through the arachnoid villi
of African green monkeys suggested the diameter of arachnoid
villi channels to be in the range of 4–12 µm (from histological
data). Moreover, there was no discrimination in the passage
between a variety of various sized particles as long as they were
under the threshold value; which does not depend only on
the diameter but also on the shape, the consistency as well as
the surface properties associated with the particles (Welch and
Pollay, 1961).

Arachnoid Villi/Granulations Pathway

Peripheral Lymphatic Pathways

Our classic textbook understanding of the role of the arachnoid
villi/granulations in CSF transport comes from a study
conducted over 100 years ago in the cadaver brain, under
non-physiologically high CSF pressures (Weed, 1914). Our
understanding is as follows: the CSF drains into the venous
sinuses via the arachnoid villi/granulations and this is a
major route of exit for the CSF as indicated in Figure 1Ci.
However, recent studies have cast doubt on this understanding,
inviting scientists to rethink the exact role and magnitude
of the arachnoid villi/granulation route. Using high-resolution
stereomicroscope and lymphatic-reporter mice, Ma et al. (2017)
demonstrated that the lymphatic pathway, rather than the
arachnoid villi/granulations, was the major outflow pathway
for small and large molecular weight CSF tracers. Moreover,
an MRI study conducted on normal and hydrocephalic rats,
indicated that the superior sagittal sinus was not a significant
draining channel for ventricular CSF tracers compared to the
azygos internal cerebral vein, suggesting direct exit of the CSF
tracer via the parenchymal venous circulation as opposed to
exiting via the arachnoid villi/granulations (Krishnamurthy et al.,
2018). To address the role of arachnoid granulations in the
outflow of CSF, a recent study investigated the morphology of the
arachnoid granulations in pigs utilizing electron microscopy and
immunohistochemistry. They identified the cranial arachnoid
granulation-like dural gap (CAG-LDG) in the meninges adjacent
to the superior sagittal sinus however, they did not find
CAG-LDG in the dura mater adjacent to the transverse sinus.
They also demonstrated the lymphatic endothelial cell marker,
Lyve-1 in the CAG-LDG in pigs, revealing characteristics similar
to the lymphatic endothelium. This study provides a basis for
further research of CSF drainage via these pathways and its
relation to WC-associated diseases in humans (Kutomi and
Takeda, 2020).
Nonetheless, historically, early studies of CSF transport from
subarachnoid space to the vascular circulatory system suggested
the presence of arachnoid villi/granulations located in the dura
mater of the venous sinuses, providing an open unidirectional
pathway connecting the meninges with the venous system
(Welch and Pollay, 1961; Pollay, 2010). Arachnoid villi are
solely depressions that are not fully penetrated into the dural
wall before birth (Gomez et al., 1983; le Gros Clark, 1920).
Arachnoid villi become functional and continue to grow with
maturation and with an increase in CSF pressure (le Gros

It has been known for a long time that CSF drains via the
perineural spaces of the cranial nerves, especially CNI in the nasal
mucosa pathway for WC into the peripheral lymphatics outside
the cranium; the nasal mucosa pathway acts as a major clearance
route after intracisternal or intraventricular injections (Ma et al.,
2017). However, several researchers have found drainage of CSF
tracers along the perineural spaces of the other cranial nerves,
complementary to the nasal mucosa pathway.
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Nasal Mucosa Pathway
Many studies provide evidence for the nasal lymphatic pathway
as the major pathway for CSF drainage, via channels in
the cribriform plate of the ethmoid bone draining into the
CLNs (Kida et al., 1993; Johnston et al., 2004) as indicated
in Figure 1Cii. Macromolecular waste solutes such as Indian
ink, albumin, Evans blue dye, etc. (Kida et al., 1993; Nagra
et al., 2006), and immune cells such as GFP-expressing CD4 T
lymphocytes, GFP monocytes, et cetera (Goldmann et al.,
2006; Kaminski et al., 2012), all have been shown to exit the
CNS through the nasal mucosa into the CLNs. Injection of
radio-iodinated albumin into the caudate nucleus of rabbits
demonstrated the drainage into deep cervical lymph nodes
(dCLNs) majorly via the nasal submucosa, suggesting that the
protein first passed through the cerebral perivenous spaces and
then mainly entered the subarachnoid space of the ipsilateral
olfactory lobe through the cribriform plate into the submucous
space of the nose (Bradbury et al., 1981). Subsequent experiments
in rabbits confirmed the major connection between CSF and
dCLNs via the subarachnoid space prolongations around CNI
into the nasal submucosa (Bradbury and Westrop, 1983); these
experiments also showed that some solutes (depending on their
molecular weight) leave the extracellular fluid in the nasal
mucosa via peripheral capillary walls and drain into the blood.
Similarly, the intraventricular injection of radiolabelled colloid in
both rabbits and cats showed the passage of the tracer from nasal
mucosa subsequently into the CLNs (Pile-Spellman et al., 1984).
Kida et al. (1993) demonstrated that carbon particles reached into
the lymphatics of the nasal submucosa via some discrete channels
from the subarachnoid space of the olfactory bulb, following
cisterna magna injection of Indian ink into the rats. Mollanji et al.
(2001, 2002) also demonstrated the significance of the olfactorylymphatic route over the arachnoid villi/granulations route, and
represented it as a major drainage site for CSF transport by
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the spinal subarachnoid space to the lymphatics via perineural
routes; as well as exit along the perineural spaces of cranial
nerves (CNI, CNII, and CNV). In a previous study, we have
demonstrated that all 12 pairs of cranial nerves and all 31 pairs of
spinal nerves are surrounded with CSF in humans, which drain
to regional peripheral lymphatics (Fahmy et al., 2021).
Although the utility of perineural spaces, peripheral lymphatic
vessels, and CLNs in brain WC have been extensively studied,
especially, after intraventricular or intracisternal injections, it
remains unclear if perineural routes are the major routes for WC
after the intraparenchymal injections (Ma et al., 2017). Moreover,
it is not known if the waste solutes drain along the cranial nerves
or actually enter the epineurium and then drain within the nerves
along fascicles and/or axons (Benveniste et al., 2019). Therefore,
further research is warranted in order to investigate the exact
mechanism and role of the CSF-lymphatic pathway in brain WC.

blocking the cribriform plate in sheep; indicating an increase
in the resting intracranial pressure and a significant reduction
in CSF clearance. Moreover, studies performed in sheep, pigs,
rabbits, rats, mice, monkeys, and humans using injections of
yellow Microfil into the CSF compartment identified the nasal
lymphatic pathway as distinctive for CSF absorption in all
mammals, showing the similar distribution of Microfil across
all species (Johnston et al., 2004). More recent animal studies
have also demonstrated similar findings and reached similar
conclusions (Liu et al., 2012; Ma et al., 2017; Krishnamurthy et al.,
2018). However, despite the crucial role of the nasal lymphatic
pathway in the evacuation of molecular waste solutes from the
CSF in various animal species, a recent in vivo MRI study in
humans showed that, although CSF tracer (gadobutrol) was
found near/below the cribriform plate, no significant amount
of tracer reached the nasal mucosa itself, which questions
the presence of this pathway in humans and warrants further
research (Melin et al., 2020).

Meningeal Lymphatic Pathway
The presence of the meningeal lymphatic vessels was first
introduced by Paolo Mascagni, an Italian physician at the end of
the 18th century. He was an excellent anatomist, famous for his
anatomical wax models with his scientific concern in lymphatic
vessels in meninges. His work presented 28 wax models on the
lymphatic system including three body-size models. However,
his ideas on lymphatic vessels were not assessed for their value
by contemporary researchers and forgotten (Lukić et al., 2003;
Bucchieri et al., 2015; Da Mesquita et al., 2018a). In 1953, another
Italian scientist inspected 30 human dura for lymphatic vessels
and found them in only four dura (Lecco, 1953; Bucchieri et al.,
2015). Later in 1996, Li et al. (1996) found the meningeal stomata
in humans’ dura mater using a scanning electron microscope.
However, they assumed the meningeal stomata to be a part of
the prelymphatic capillary system, helping with cerebral lymph
drainage. Mascagni’s observations were finally confirmed and
presented in detail in 2015 when Louveau et al. (2015) identified
the meningeal lymphatic vessels in mice lining the dural venous
sinuses and demonstrated their ability to carry fluid and immune
cells (such as T cells, MHCII+ , CD11c+ , and B220+ , etc.) to
the dCLNs. They also suggested that the meningeal lymphatic
vessels were the primary route for the CSF-lymphatic pathway
as compared to the nasal mucosa pathway. Also, the meningeal
lymphatic vessels seemed to form a more complex and larger
network along the transverse sinus, as compared to the superior
sagittal sinus. They indicated that the transverse sinus meningeal
lymphatic vessels may help in ISF and interstitial waste products
clearance from the brain parenchyma, following their entry
into the CSF compartment through the recently discovered
glymphatic system pathway. At around the same time in 2015,
Aspelund et al. demonstrated the presence of the meningeal
lymphatic vessels in the dura mater of the CNS in mice and their
exit via foramina at the base of the skull alongside the blood
vasculature (arteries, veins) and cranial nerves (Aspelund et al.,
2015) as indicated in Figure 1Ciii. Their data also suggested
the clearance of ISF/CSF and interstitial waste products from
the brain parenchyma to the dCLNs via meningeal lymphatic
vessels after they traversed the glymphatic pathway. Another
study on mice showed the meningeal lymphatic vessels as the

Other Perineural Spaces
CSF drainage from the subarachnoid space to the lymphatics
outside the CNS is associated with the transport along cranial
and spinal nerves (Brierley and Field, 1948; Zakharov et al., 2003;
Krishnamurthy et al., 2018). Various studies have investigated
the perineural routes along CNI (as discussed in the previous
section) for CSF drainage into the CLNs, as the major
CSF-lymphatic pathway (Kida et al., 1993; Johnston et al., 2004;
Koh et al., 2005). Complementary to this nasal mucosa pathway,
other studies have suggested the drainage of CSF tracer into
extracranial peripheral lymphatics via perineural spaces of other
cranial nerves. Arnold et al. (1972) showed the presence of
contrast agent, radioisotopes in the perineural spaces of CNI,
and the vestibulocochlear nerve (CNVIII) in guinea pigs a
few minutes following CSF tracer injection, with most of the
tracer ending up in dCLNs. Kida et al. (1993) observed the
distribution of carbon particles along the perineural spaces of
CNI, CNII, and the oculomotor nerve (CNIII) following the
injection of Indian Ink into the cisterna magna of rats. Injection
of radiolabeled albumin in the lateral ventricles of sheep also
identified the perineural spaces along CNI, CNII, and CNVIII
(Boulton et al., 1996). Moreover, Microfil infusion in the cisterna
magna of neonatal sheep showed distribution along various
cranial and spinal nerves; identifying the perineural routes along
the trigeminal (CNV), the facial (CNVII), glossopharyngeal
(CNIX), vagal (CNX), and hypoglossal (CNXII) nerves, with
ultimate drainage into the extracranial lymphatics (Zakharov
et al., 2003). Lee et al. (2015) demonstrated MRI CSF tracer
(Gd-DTPA) distribution around/inside the cochlea (CNVIII)
and pronounced efflux along CNX. Recently, Ma et al. (2017)
found evidence of tracer exiting the perineural routes along
CNI, CNII, and CNV in mice after intraventricular infusion.
They also detected tracer exiting from the jugular foramina
along CNIX, CNX, and accessory (CNXI) nerves, as well as
from the stylomastoid foramina along CNVII, which ultimately
drained to the dCLNs. Recently, Krishnamurthy et al. (2018)
showed the distribution of MRI-labeled dextran along the spinal
nerves, suggesting these nerves as the CSF outflow pathways from
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drainage channel for macromolecules and immune cells in
the CSF. They also revealed certain spots called ‘‘hot spots’’
along some meningeal lymphatic vessels which take up the
tracer from CSF quickly after the injection as compared to
other areas of the lymphatic vessels (Louveau et al., 2018). A
recent study in mice showed the distinct morphological features
of meningeal lymphatic vessels in the dorsal and basal dura
along with their anatomical locations. They also demonstrated
the basal meningeal lymphatic vessels as the hotspot for
CSF macromolecular clearance and showed the impairment of
meningeal lymphatic vessels and delayed CSF clearance with
aging (Ahn et al., 2019).
Subsequently, the existence of the meningeal lymphatic
vessels was reported using non-invasive, high-resolution clinical
MRI in humans (Absinta et al., 2017; Naganawa et al., 2020)
and non-human primates (Absinta et al., 2017). Another study
in healthy human subjects showed the direction of lymphatic
flow in meningeal lymphatic vessels to be opposite to the
direction of venous flow in the superior sagittal sinus utilizing
high-resolution MRI; suggesting it to reach the cribriform
plate based on directionality (Kuo et al., 2018). Studies
using confocal microscopy confirmed the presence of these
meningeal lymphatic vessels in humans and indicated that,
although these vessels served as potential efflux pathways for Aβ
clearance from the brain, Aβ did not deposit in or around the
meningeal lymphatic vessels (Goodman et al., 2018). Moreover,
experiments in mice demonstrated that impairments to the
meningeal lymphatic vessels were associated with decreased
macromolecular influx and efflux in the perivascular spaces,
which resulted in the accumulation of Aβ in the brain
parenchyma (Da Mesquita et al., 2018b). This study also
demonstrated a decrease in the diameter of meningeal lymphatic
vessels in old mice and suggested the role of these vessels in
AD pathology as well as in cognitive decline with aging. A
recent human study identified the clearance of MRI contrast
agent (gadodiamide) in putative meningeal lymphatic vessels,
and the glymphatic system and suggested the impairment of both
pathways with aging (Zhou et al., 2020). Another recent study
in mice demonstrated that dorsal meningeal lymphatic vessels
are critical for generating an effective immune response against
brain tumors (Hu et al., 2020). Thus, the meningeal lymphatic
vessels provide a route for draining macromolecules and immune
cells from the CNS and therefore constitute a possible therapeutic
target for the treatment of various neurodegenerative disorders.

to the brain parenchyma. It is a difficult task to classify these
pathways by level of importance, as the scientific community
remains unsure of the relative contribution of each of these
pathways is to the overall process of brain WC. It may very
well be that all these pathways must work in concert to ensure
the effective and proper removal of toxic waste products from
the brain and ensure healthy neuronal functioning. Further
investigations are needed to synchronously assess the full picture
of brain WC. Specifically, further investigations should include:
(1) reexamination of fluid flow in the perivascular spaces
as well as its directionality to resolve discrepancies between
the glymphatic system and IPAD pathways; (2) evaluation of
the role of AQP4 channels in perivascular spaces and brain
parenchyma tracer distribution; (3) sophisticated modeling
techniques including convective bulk flow coexisting with
diffusion within the brain parenchyma to represent more realistic
glymphatic flow; (4) reliable mathematical glymphatic system
models using the periarterial space as elliptical instead of the
circular annulus; (5) determination of the exact location of
the meningeal lymphatic vessels within the meningeal layers
in various species and the mechanism of CSF exit into these
vessels; (6) develop directionality/causation to the association
between glymphatic dysfunction and neurological diseases,
in order to develop clinical therapeutics; (7) reexamination
of the arachnoid villi/granulations for their possible role
in CSF outflow; and (8) in vivo reexamination of the
nasal lymphatic pathway via the cribriform plate in the
humans.
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